Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11583513 Semifluorinated alkane compositions

Patent 11583513 was granted and assigned to Novaliq on February, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

February 21, 2023

Patent Application Number

16783972

Date Filed

February 6, 2020

Patent Citations

US Patent 10045996 Pharmaceutical composition for treatment of increased intraocular pressure

US Patent 10507132 Topical administration method

US Patent 10813976 Ophthalmic compositions comprising ciclosporin

US Patent 10813999 Topical pharmaceutical composition based on semifluorinated alkanes

Patent Citations Received

US Patent 12005033 Compositions comprising mixtures of semifluorinated alkanes

0

US Patent 12059449 Ophthalmic composition for treatment of dry eye disease

0

US Patent 12128010 Semifluorinated compounds and their compositions

0

Patent Primary Examiner

Theodore R. Howell

CPC Code

...

The invention provides novel compositions comprising semifluorinated alkanes and at least one compound sensitive or prone to oxidation. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue. The invention further provides kits comprising such compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11583513 Semifluorinated alkane compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool